StockData
ACONNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as ACONW

Aclarion, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.89+0.04 (+2.16%)

Close on Oct 19, 2026

Market cap
$4.65M
P/E (TTM)
–
Dividend yield
–

Aclarion, Inc. revenue by segment

No segment breakdown reported

Aclarion does not break out revenue by segment, region or product in the tagged data of its filings for this period type.